Helen Torley Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Helen Torley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Helen Torley. Helen Torley is EVP, Chief Commercial Officer in ONYX PHARMACEUTICALS INC ($ONXX).
Latest Insider Trading Transactions of Helen Torley
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | D | 88.86 | 24,300 | 2,159,298 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | D | 37.68 | 12,156 | 458,038 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | D | 37.68 | 1,144 | 43,106 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | D | 33.70 | 44,132 | 1,487,248 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | D | 33.70 | 11,868 | 399,952 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | D | 125.00 | 28,575 | 3,571,875 | 0 | 28.6 K to 0 (-100.00 %) |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | U | 125.00 | 7,336 | 917,000 | 28,575 | 35.9 K to 28.6 K (-20.43 %) |
| Sep 05 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Payment of Exercise | F | 123.62 | 2,099 | 259,478 | 35,911 | 38 K to 35.9 K (-5.52 %) |
| Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 37.68 | 1,250 | 47,100 | 13,300 | |
| Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 33.70 | 7,000 | 235,900 | 56,000 | |
| Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 126.93 | 1,061 | 134,667 | 46,585 | 47.6 K to 46.6 K (-2.23 %) |
| Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 126.89 | 8,250 | 1,046,810 | 47,646 | 55.9 K to 47.6 K (-14.76 %) |
| Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 37.68 | 1,250 | 47,100 | 55,896 | 54.6 K to 55.9 K (+2.29 %) |
| Aug 14 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 33.70 | 7,000 | 235,900 | 54,646 | 47.6 K to 54.6 K (+14.69 %) |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 37.68 | 1,250 | 47,100 | 14,450 | |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 33.70 | 7,000 | 235,900 | 63,000 | |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 97.26 | 1,000 | 97,260 | 47,646 | 48.6 K to 47.6 K (-2.06 %) |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 98.28 | 2,500 | 245,690 | 48,646 | 51.1 K to 48.6 K (-4.89 %) |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 98.78 | 3,000 | 296,352 | 51,146 | 54.1 K to 51.1 K (-5.54 %) |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 97.32 | 1,750 | 170,308 | 54,146 | 55.9 K to 54.1 K (-3.13 %) |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 33.70 | 7,000 | 235,900 | 55,896 | 48.9 K to 55.9 K (+14.32 %) |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 37.68 | 1,250 | 47,100 | 48,896 | 47.6 K to 48.9 K (+2.62 %) |
| Apr 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 86.14 | 466 | 40,141 | 47,646 | 48.1 K to 47.6 K (-0.97 %) |
| Apr 01 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | A | 88.86 | 24,300 | 2,159,298 | 24,300 | |
| Apr 01 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Grant | A | 0.00 | 8,600 | 0 | 48,112 | 39.5 K to 48.1 K (+21.77 %) |
| Feb 06 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 37.68 | 1,250 | 47,100 | 15,800 | |
| Feb 06 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 33.70 | 7,000 | 235,900 | 70,000 | |
| Feb 06 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 78.61 | 8,250 | 648,533 | 39,512 | 47.8 K to 39.5 K (-17.27 %) |
| Feb 06 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 37.68 | 1,250 | 47,100 | 47,762 | 46.5 K to 47.8 K (+2.69 %) |
| Feb 06 2013 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 33.70 | 7,000 | 235,900 | 46,512 | 39.5 K to 46.5 K (+17.72 %) |
| Nov 30 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 37.68 | 1,250 | 47,100 | 17,050 | |
| Nov 30 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Option Exercise | M | 33.70 | 7,000 | 235,900 | 77,000 | |
| Nov 30 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 75.22 | 11,997 | 902,414 | 39,512 | 51.5 K to 39.5 K (-23.29 %) |
| Nov 30 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 37.68 | 1,250 | 47,100 | 51,509 | 50.3 K to 51.5 K (+2.49 %) |
| Nov 30 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Buy | M | 33.70 | 7,000 | 235,900 | 50,259 | 43.3 K to 50.3 K (+16.18 %) |
| Oct 05 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 86.51 | 2,314 | 200,184 | 43,259 | 45.6 K to 43.3 K (-5.08 %) |
| Sep 06 2012 | ONXX | ONYX PHARMACEUTICA ... | Torley Helen | EVP, Chief Commerci ... | Sell | S | 72.78 | 1,878 | 136,681 | 56,823 | 58.7 K to 56.8 K (-3.20 %) |
Page: 1